Skip to main content

Peer Review reports

From: The Procalcitonin And Survival Study (PASS) – A Randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients

Original Submission
6 Jun 2008 Submitted Original manuscript
26 Jun 2008 Author responded Author comments - Jens-Ulrik Jensen
Resubmission - Version 2
26 Jun 2008 Submitted Manuscript version 2
3 Jul 2008 Author responded Author comments - Jens-Ulrik Jensen
Resubmission - Version 3
3 Jul 2008 Submitted Manuscript version 3
Publishing
13 Jul 2008 Editorially accepted
13 Jul 2008 Article published 10.1186/1471-2334-8-91

You can find further information about peer review here.

Back to article page